Last 12 months
Inside the activity.
5 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 4 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 25, 2017 Filed May 26, 2017 17:34 UTC |
Meridian OHC Partners, LPDirector · 10% owner
Meridian TSV II, LPDirector · 10% owner
TSV Investment Partners, LLCDirector · 10% owner
BlueLine Capital Partners II, L.P.Director · 10% owner
BlueLine Partners, L.L.C.Director · 10% owner
|
PurchaseCommon Stock | 5,000 | $1.55 | $7,750.00 |
DisclosureSEC source: 0001445866-17-000793 · form4.xml · nonDerivative · entry 2 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,666,410 F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| May 24, 2017 Filed May 26, 2017 17:34 UTC |
Meridian OHC Partners, LPDirector · 10% owner
Meridian TSV II, LPDirector · 10% owner
TSV Investment Partners, LLCDirector · 10% owner
BlueLine Capital Partners II, L.P.Director · 10% owner
BlueLine Partners, L.L.C.Director · 10% owner
|
PurchaseCommon Stock | 1,105 | $1.55 | $1,712.75 |
DisclosureSEC source: 0001445866-17-000793 · form4.xml · nonDerivative · entry 1 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,661,410 F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| May 19, 2017 Filed May 19, 2017 21:34 UTC |
Morris Ryan J.Director
|
PurchaseCommon Stock | 15,000 | $1.28 | $19,249.50 |
DisclosureSEC source: 0001014108-17-000108 · primary_doc.xml · nonDerivative · entry 2 Morris Ryan J. · CIK 0001535780 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Disclosed balance after: 743,262 F2 · ownership.nature: Shares beneficially owned by Meson Capital Partners LP ("Meson LP"). As the general partner of Meson LP, Meson LLC may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) the Meson LP shares. Meson LLC does not own any shares of Common Stock directly and disclaims beneficial ownership of the Meson LP shares. As managing member of Meson LLC, Mr. Morris may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) any shares of Common Stock beneficially owned by Meson LLC. Mr. Morris disclaims beneficial ownership of any shares of Common Stock beneficially owned by Meson LLC. Read SEC document |
| May 17, 2017 Filed May 18, 2017 19:57 UTC |
Morris Ryan J.Director
|
PurchaseCommon Stock | 9,614 | $1.35 | $12,978.90 |
DisclosureSEC source: 0001014108-17-000103 · primary_doc.xml · nonDerivative · entry 3 Morris Ryan J. · CIK 0001535780 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Disclosed balance after: 728,262 F2 · ownership.nature: Shares beneficially owned by Meson Capital Partners LP ("Meson LP"). As the general partner of Meson LP, Meson LLC may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) the Meson LP shares. Meson LLC does not own any shares of Common Stock directly and disclaims beneficial ownership of the Meson LP shares. As managing member of Meson LLC, Mr. Morris may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) any shares of Common Stock beneficially owned by Meson LLC. Mr. Morris disclaims beneficial ownership of any shares of Common Stock beneficially owned by Meson LLC. Read SEC document |
| May 16, 2017 Filed May 18, 2017 19:57 UTC |
Morris Ryan J.Director
|
PurchaseCommon Stock | 20,000 | $1.49 | $29,828.00 |
DisclosureSEC source: 0001014108-17-000103 · primary_doc.xml · nonDerivative · entry 2 Morris Ryan J. · CIK 0001535780 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Disclosed balance after: 718,648 F2 · ownership.nature: Shares beneficially owned by Meson Capital Partners LP ("Meson LP"). As the general partner of Meson LP, Meson LLC may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) the Meson LP shares. Meson LLC does not own any shares of Common Stock directly and disclaims beneficial ownership of the Meson LP shares. As managing member of Meson LLC, Mr. Morris may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) any shares of Common Stock beneficially owned by Meson LLC. Mr. Morris disclaims beneficial ownership of any shares of Common Stock beneficially owned by Meson LLC. Read SEC document |
| March 27, 2017 Filed Mar 28, 2017 20:10 UTC |
Morris Ryan J.Director
|
PurchaseCommon Stock | 21,651 | $2.20 | $47,632.20 |
DisclosureSEC source: 0001014108-17-000074 · primary_doc.xml · nonDerivative · entry 2 Morris Ryan J. · CIK 0001535780 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Disclosed balance after: 698,648 F2 · ownership.nature: Shares beneficially owned by Meson Capital Partners LP ("Meson LP"). As the general partner of Meson LP, Meson LLC may be deemed to have the shared power to vote or direct vote of (and the shared power to dispose or direct the disposition of) the Meson LP shares. Meson LLC does not own any shares of Common Stock directly and disclaims beneficial ownership of the Meson LP shares. As managing member of Meson LLC, Mr. Morris may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) any shares of Common Stock beneficially owned by Meson LLC. Mr. Morris disclaims beneficial ownership of any shares of Common Stock beneficially owned by Meson LLC. Read SEC document |
| March 24, 2017 Filed Mar 27, 2017 18:51 UTC |
Morris Ryan J.Director
|
PurchaseCommon Stock | 94,200 | $2.14 | $201,729.30 |
DisclosureSEC source: 0001014108-17-000072 · primary_doc.xml · nonDerivative · entry 2 Morris Ryan J. · CIK 0001535780 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Disclosed balance after: 676,997 F2 · ownership.nature: Shares beneficially owned by Meson Capital Partners LP ("Meson LP"). As the general partner of Meson LP, Meson LLC may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) the Meson LP shares. Meson LLC does not own any shares of Common Stock directly and disclaims beneficial ownership of the Meson LP shares. As managing member of Meson LLC, Mr. Morris may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) any shares of Common Stock beneficially owned by Meson LLC. Mr. Morris disclaims beneficial ownership of any shares of Common Stock beneficially owned by Meson LLC. Read SEC document |
| March 16, 2017 Filed Mar 22, 2017 15:14 UTC |
Skonieczny JanetEVP & Chief Operating Officer
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0001014108-17-000070 · primary_doc.xml · derivative · entry 1 Skonieczny Janet · CIK 0001418854 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2027-03-16 F1 · derivative.exercise_date: The option, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vests in 36-monthly installments beginning April 16, 2017. Read SEC document |
| March 16, 2017 Filed Mar 22, 2017 18:59 UTC |
Steen Eric KDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0001014108-17-000069 · primary_doc.xml · derivative · entry 1 Steen Eric K · CIK 0001572871 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2027-03-16 F1 · derivative.exercise_date: The option, representing the right to purchase a total of 30,000 shares of InfuSystem Holdings, Inc. common stock, vests in 36-monthly installments beginning April 16, 2017. Read SEC document |
| March 16, 2017 Filed May 4, 2017 19:23 UTC |
Smith Trent N.Exec VP,CAO & Corp Controller
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0001014108-17-000096 · primary_doc.xml · derivative · entry 1 Smith Trent N. · CIK 0001705689 · Exec VP,CAO & Corp Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2027-03-16 F1 · derivative.exercise_date: The option, representing the right to purchase a total of 20,000 shares of InfuSystem Holdings, Inc. common stock, vests in 36-monthly installments beginning on April 16, 2017. Read SEC document |
| March 16, 2017 Filed May 5, 2017 21:16 UTC |
Downs Christopher SCFO (interim)
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0001014108-17-000099 · primary_doc.xml · derivative · entry 1 Downs Christopher · CIK 0001705978 · CFO (interim) 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2027-03-16 F1 · derivative.exercise_date: The option, representing the right to purchase a total of 20,000 shares of InfuSystem Holdings, Inc. common stock, vests in 36-monthly installments beginning April 16, 2017. Read SEC document |
| March 16, 2017 Filed May 18, 2017 20:49 UTC |
Dilorio RichardExecutive Vice President
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0001014108-17-000105 · primary_doc.xml · derivative · entry 1 Dilorio Richard · CIK 0001706994 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2027-03-16 F1 · derivative.exercise_date: The option, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vests in 36-monthly installments beginning April 16, 2017. Read SEC document |
| January 18, 2017 Filed Jan 27, 2017 21:22 UTC |
Shuda ScottDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $2.39 | $0.00 |
DisclosureSEC source: 0001014108-17-000014 · primary_doc.xml · derivative · entry 1 Shuda Scott · CIK 0001486636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2027-01-18 F1 · derivative.exercise_date: The option, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vests in twelve monthly installments beginning February 18, 2017. Read SEC document |
| January 18, 2017 Filed Jan 27, 2017 16:27 UTC |
WHITTERS JOSEPH EDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $2.39 | $0.00 |
DisclosureSEC source: 0001014108-17-000015 · primary_doc.xml · derivative · entry 1 WHITTERS JOSEPH E · CIK 0001186680 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2027-01-18 F1 · derivative.exercise_date: The option, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vests in twelve monthly installments beginning February 18, 2017. Read SEC document |
| January 18, 2017 Filed Jan 27, 2017 16:10 UTC |
DREYER DAVID CDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $2.39 | $0.00 |
DisclosureSEC source: 0001014108-17-000012 · primary_doc.xml · derivative · entry 1 DREYER DAVID C · CIK 0001203607 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2027-01-18 F1 · derivative.exercise_date: The option, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vests in twelve monthly installments beginning February 18, 2017. Read SEC document |
| January 18, 2017 Filed Jan 27, 2017 21:16 UTC |
Morris Ryan J.Director
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $2.39 | $0.00 |
DisclosureSEC source: 0001014108-17-000013 · primary_doc.xml · derivative · entry 1 Morris Ryan J. · CIK 0001535780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2027-01-18 F1 · derivative.exercise_date: The option, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vests in twelve monthly installments beginning February 18, 2017. Read SEC document |
| January 18, 2017 Filed Jan 27, 2017 21:04 UTC |
Lehman Gregg OwenDirector
|
GrantStock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $2.39 | $0.00 |
DisclosureSEC source: 0001014108-17-000011 · primary_doc.xml · derivative · entry 1 Lehman Gregg Owen · CIK 0001376620 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2027-01-18 F1 · derivative.exercise_date: The option, representing the right to purchase a total of 60,000 shares of InfuSystem Holdings, Inc. common stock, vests in twelve monthly installments beginning February 18, 2017. Read SEC document |
| December 19, 2016 Filed Dec 19, 2016 21:37 UTC |
Steen Eric KDirector · President and CEO
|
PurchaseCommon Stock | 5,000 | $2.35 | $11,750.00 |
DisclosureSEC source: 0001014108-16-000547 · primary_doc.xml · nonDerivative · entry 3 Steen Eric K · CIK 0001572871 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,296 Read SEC document |
| December 16, 2016 Filed Dec 16, 2016 17:36 UTC |
Meridian OHC Partners, LPDirector · 10% owner
Meridian TSV II, LPDirector · 10% owner
TSV Investment Partners, LLCDirector · 10% owner
BlueLine Capital Partners II, L.P.Director · 10% owner
BlueLine Partners, L.L.C.Director · 10% owner
|
PurchaseCommon Stock | 41,717 | $2.35 | $98,034.95 |
DisclosureSEC source: 0001445866-16-003003 · form4.xml · nonDerivative · entry 4 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,651,972 F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| December 16, 2016 Filed Dec 16, 2016 17:36 UTC |
Meridian OHC Partners, LPDirector · 10% owner
Meridian TSV II, LPDirector · 10% owner
TSV Investment Partners, LLCDirector · 10% owner
BlueLine Capital Partners II, L.P.Director · 10% owner
BlueLine Partners, L.L.C.Director · 10% owner
|
PurchaseCommon Stock | 35,100 | $2.30 | $80,730.00 |
DisclosureSEC source: 0001445866-16-003003 · form4.xml · nonDerivative · entry 3 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,610,255 F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| December 16, 2016 Filed Dec 19, 2016 21:37 UTC |
Steen Eric KDirector · President and CEO
|
PurchaseCommon Stock | 2,000 | $2.34 | $4,687.40 |
DisclosureSEC source: 0001014108-16-000547 · primary_doc.xml · nonDerivative · entry 2 Steen Eric K · CIK 0001572871 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,296 Read SEC document |
| December 15, 2016 Filed Dec 16, 2016 17:36 UTC |
Meridian OHC Partners, LPDirector · 10% owner
Meridian TSV II, LPDirector · 10% owner
TSV Investment Partners, LLCDirector · 10% owner
BlueLine Capital Partners II, L.P.Director · 10% owner
BlueLine Partners, L.L.C.Director · 10% owner
|
PurchaseCommon Stock | 100,000 | $2.35 | $235,000.00 |
DisclosureSEC source: 0001445866-16-003003 · form4.xml · nonDerivative · entry 2 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,575,155 F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| December 15, 2016 Filed Dec 16, 2016 17:36 UTC |
Meridian OHC Partners, LPDirector · 10% owner
Meridian TSV II, LPDirector · 10% owner
TSV Investment Partners, LLCDirector · 10% owner
BlueLine Capital Partners II, L.P.Director · 10% owner
BlueLine Partners, L.L.C.Director · 10% owner
|
PurchaseCommon Stock | 23,183 | $2.30 | $53,320.90 |
DisclosureSEC source: 0001445866-16-003003 · form4.xml · nonDerivative · entry 1 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,475,155 F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 21:37 UTC |
Steen Eric KDirector · President and CEO
|
PurchaseCommon Stock | 5,000 | $2.30 | $11,500.00 |
DisclosureSEC source: 0001014108-16-000547 · primary_doc.xml · nonDerivative · entry 1 Steen Eric K · CIK 0001572871 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,296 F1 · balance_after: This total has been adjusted to reflect the current holdings since the last filing of a beneficial ownership report by the Reporting Person. Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 17:01 UTC |
Morris Ryan J.Director
|
PurchaseCommon Stock | 23,171 | $2.85 | $66,111.50 |
DisclosureSEC source: 0001014108-16-000513 · primary_doc.xml · nonDerivative · entry 2 Morris Ryan J. · CIK 0001535780 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 582,797 F2 · ownership.nature: Shares beneficially owned by Meson Capital Partners LP ("Meson LP"). As the general partner of Meson LP, Meson LLC may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) the Meson LP shares. Meson LLC does not own any shares of Common Stock directly and disclaims beneficial ownership of the Meson LP shares. As managing member of Meson LLC, Mr. Morris may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) any shares of Common Stock beneficially owned by Meson LLC. Mr. Morris disclaims beneficial ownership of any shares of Common Stock beneficially owned by Meson LLC. Read SEC document |
| September 13, 2016 Filed Sep 13, 2016 22:21 UTC |
Morris Ryan J.Director
|
PurchaseCommon Stock | 9,829 | $2.87 | $28,236.75 |
DisclosureSEC source: 0001014108-16-000511 · primary_doc.xml · nonDerivative · entry 4 Morris Ryan J. · CIK 0001535780 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 559,626 F2 · ownership.nature: Shares beneficially owned by Meson Capital Partners LP ("Meson LP"). As the general partner of Meson LP, Meson LLC may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) the Meson LP shares. Meson LLC does not own any shares of Common Stock directly and disclaims beneficial ownership of the Meson LP shares. As managing member of Meson LLC, Mr. Morris may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) any shares of Common Stock beneficially owned by Meson LLC. Mr. Morris disclaims beneficial ownership of any shares of Common Stock beneficially owned by Meson LLC. Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 22:21 UTC |
Morris Ryan J.Director
|
PurchaseCommon Stock | 2,000 | $2.88 | $5,760.00 |
DisclosureSEC source: 0001014108-16-000511 · primary_doc.xml · nonDerivative · entry 3 Morris Ryan J. · CIK 0001535780 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 549,797 F2 · ownership.nature: Shares beneficially owned by Meson Capital Partners LP ("Meson LP"). As the general partner of Meson LP, Meson LLC may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) the Meson LP shares. Meson LLC does not own any shares of Common Stock directly and disclaims beneficial ownership of the Meson LP shares. As managing member of Meson LLC, Mr. Morris may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) any shares of Common Stock beneficially owned by Meson LLC. Mr. Morris disclaims beneficial ownership of any shares of Common Stock beneficially owned by Meson LLC. Read SEC document |
| September 09, 2016 Filed Sep 13, 2016 22:21 UTC |
Morris Ryan J.Director
|
PurchaseCommon Stock | 5,000 | $2.89 | $14,438.00 |
DisclosureSEC source: 0001014108-16-000511 · primary_doc.xml · nonDerivative · entry 2 Morris Ryan J. · CIK 0001535780 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 547,797 F2 · ownership.nature: Shares beneficially owned by Meson Capital Partners LP ("Meson LP"). As the general partner of Meson LP, Meson LLC may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) the Meson LP shares. Meson LLC does not own any shares of Common Stock directly and disclaims beneficial ownership of the Meson LP shares. As managing member of Meson LLC, Mr. Morris may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) any shares of Common Stock beneficially owned by Meson LLC. Mr. Morris disclaims beneficial ownership of any shares of Common Stock beneficially owned by Meson LLC. Read SEC document |
| September 08, 2016 Filed Sep 8, 2016 22:21 UTC |
Morris Ryan J.Director
|
PurchaseCommon Stock | 10,000 | $2.86 | $28,575.00 |
DisclosureSEC source: 0001014108-16-000510 · primary_doc.xml · nonDerivative · entry 3 Morris Ryan J. · CIK 0001535780 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 552,797 F2 · ownership.nature: Shares beneficially owned by Meson Capital Partners LP ("Meson LP"). As the general partner of Meson LP, Meson LLC may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) the Meson LP shares. Meson LLC does not own any shares of Common Stock directly and disclaims beneficial ownership of the Meson LP shares. As managing member of Meson LLC, Mr. Morris may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) any shares of Common Stock beneficially owned by Meson LLC. Mr. Morris disclaims beneficial ownership of any shares of Common Stock beneficially owned by Meson LLC. Read SEC document |
| September 06, 2016 Filed Sep 8, 2016 22:21 UTC |
Morris Ryan J.Director
|
PurchaseCommon Stock | 7,171 | $2.82 | $20,243.02 |
DisclosureSEC source: 0001014108-16-000510 · primary_doc.xml · nonDerivative · entry 2 Morris Ryan J. · CIK 0001535780 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 542,797 F2 · ownership.nature: Shares beneficially owned by Meson Capital Partners LP ("Meson LP"). As the general partner of Meson LP, Meson LLC may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) the Meson LP shares. Meson LLC does not own any shares of Common Stock directly and disclaims beneficial ownership of the Meson LP shares. As managing member of Meson LLC, Mr. Morris may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) any shares of Common Stock beneficially owned by Meson LLC. Mr. Morris disclaims beneficial ownership of any shares of Common Stock beneficially owned by Meson LLC. Read SEC document |
| September 02, 2016 Filed Sep 6, 2016 16:57 UTC |
Morris Ryan J.Director
|
PurchaseCommon Stock | 2,600 | $2.84 | $7,371.26 |
DisclosureSEC source: 0001014108-16-000509 · primary_doc.xml · nonDerivative · entry 2 Morris Ryan J. · CIK 0001535780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,094 F1 · ownership.direct: As an entity managed by Mr. Morris, Meson Capital Partners LLC ("Meson LLC"), may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) the shares held by Mr. Morris. Meson LLC disclaims beneficial ownership of such shares. Read SEC document |
| September 01, 2016 Filed Sep 6, 2016 16:57 UTC |
Morris Ryan J.Director
|
PurchaseCommon Stock | 2,000 | $2.85 | $5,699.00 |
DisclosureSEC source: 0001014108-16-000509 · primary_doc.xml · nonDerivative · entry 1 Morris Ryan J. · CIK 0001535780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,494 F1 · ownership.direct: As an entity managed by Mr. Morris, Meson Capital Partners LLC ("Meson LLC"), may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) the shares held by Mr. Morris. Meson LLC disclaims beneficial ownership of such shares. Read SEC document |
| August 18, 2016 Filed May 4, 2017 19:17 UTC |
Smith Trent N.Exec VP,CAO & Corp Controller
|
GrantStock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $2.76 | $0.00 |
DisclosureSEC source: 0001014108-17-000095 · primary_doc.xml · derivative · entry 1 Smith Trent N. · CIK 0001705689 · Exec VP,CAO & Corp Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2026-08-18 F1 · derivative.exercise_date: The option, representing the right to purchase a total of 60,000 shares of InfuSystem Holdings, Inc. common stock, vests in 36-monthly installments beginning on September 18, 2016. Read SEC document |
| August 18, 2016 Filed May 5, 2017 21:11 UTC |
Downs Christopher SCFO (interim)
|
GrantStock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $2.76 | $0.00 |
DisclosureSEC source: 0001014108-17-000098 · primary_doc.xml · derivative · entry 1 Downs Christopher · CIK 0001705978 · CFO (interim) 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2026-08-18 F1 · derivative.exercise_date: The option, representing the right to purchase a total of 60,000 shares of InfuSystem Holdings, Inc. common stock, vests in 36-monthly installments beginning September 18, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.